Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients

Maria Vincenza Mastrolia^{1

2}, Sarah Abu-Rumeileh³, Ilaria Maccora^{1

2}, Valerio Maniscalco¹, Edoardo Marrani¹, Ilaria Pagnini¹, Andrea Taddio⁴, Gabriele Simonini^{1

2}

Affiliations

¹ Rheumatology Unit, ERN ReCONNET center, Meyer Children's Hospital IRCCS, Firenze, Italy.
² NEUROFARBA Department, University of Florence, Firenze, Italy.
³ Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
⁴ Institute for Maternal and Child Health IRCCS Burlo Garofolo, and University of Trieste, Italy.

Editorial

Maria Vincenza Mastrolia et al. Expert Rev Clin Immunol. 2024 Nov.

. 2024 Nov;20(11):1293-1295.

doi: 10.1080/1744666X.2024.2384703. Epub 2024 Jul 30.

Maria Vincenza Mastrolia^{1

2}, Sarah Abu-Rumeileh³, Ilaria Maccora^{1

2}, Valerio Maniscalco¹, Edoardo Marrani¹, Ilaria Pagnini¹, Andrea Taddio⁴, Gabriele Simonini^{1

2}

¹ Rheumatology Unit, ERN ReCONNET center, Meyer Children's Hospital IRCCS, Firenze, Italy.
² NEUROFARBA Department, University of Florence, Firenze, Italy.
³ Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
⁴ Institute for Maternal and Child Health IRCCS Burlo Garofolo, and University of Trieste, Italy.

No abstract available

Keywords: anakinra; steroid naïve; systemic idiopathic juvenile arthritis; window of opportunity.

Publication types